Sandoz Gains An Edge With High-Concentration US Humira Biosimilar
Hyrimoz Version Of Adalimumab Approved By FDA In Citrate-Free 100mg/ml Form
• By David Wallace
Sandoz now has FDA approval for both high and low strength adalimumab • Source: Shutterstock 
